Related references
Note: Only part of the references are listed.AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D. Black et al.
PSYCHOPHARMACOLOGY (2011)
Disturbed prepulse inhibition in patients with schizophrenia is consequential to dysfunction of selective attention
Kirsty E. Scholes et al.
PSYCHOPHYSIOLOGY (2010)
Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits
Kirsty Elizabeth Scholes et al.
PSYCHOPHARMACOLOGY (2009)
Stimulus quality affects expression of the acoustic startle response and prepulse inhibition in mice
C. W. Stoddart et al.
BEHAVIORAL NEUROSCIENCE (2008)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa H. M. Moore et al.
LANCET (2007)
Attention-dependent reduction in prepulse inhibition of the startle reflex in cannabis users and schizophrenia patients - A pilot study
Karina K. Kedzior et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Anxiolytic-like properties of the anandamide transport inhibitor AM404
Marco Bortolato et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans
Karina K. Kedzior et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice
Hiroshi Nagai et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat
EG Meloni et al.
JOURNAL OF NEUROSCIENCE (2006)
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice
LE Long et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Comorbid substance use and age at onset of schizophrenia
TRE Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Prenatal exposure to a cannabinold receptor agonist does not affect sensorimotor gating in rats
M Bortolato et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Substance misuse and psychiatric illness: prospective observational study using the general practice research database
M Frisher et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2005)
Apomorphine effects on emotional modulation of the startle reflex in rats
MT Martin-Iverson et al.
PSYCHOPHARMACOLOGY (2005)
Differences in prepulse inhibition (PPI) between Wistar and Sprague-Dawley rats clarified by a new method of PPI standardization
DA Hince et al.
BEHAVIORAL NEUROSCIENCE (2005)
Interaction of corticosterone and nicotine in regulation of prepulse inhibition in mice
N Ingram et al.
NEUROPHARMACOLOGY (2005)
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats
M Bortolato et al.
PSYCHOPHARMACOLOGY (2005)
Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior
VB Risbrough et al.
JOURNAL OF NEUROSCIENCE (2004)
Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice
M van den Buuse et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats
JF Cheer et al.
JOURNAL OF NEUROSCIENCE (2004)
GABAA receptors modulate cannabinoid-evoked hypothermia
SM Rawls et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls
BB Quednow et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats
M Schneider et al.
NEUROPSYCHOPHARMACOLOGY (2003)
8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment
A Czyrak et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Amphetamine effects on prepulse inhibition across-species: Replication and parametric extension
NR Swerdlow et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Cannabis-sensitive dopaminergic markers in postmortem central nervous system: Changes in schizophrenia
B Dean et al.
BIOLOGICAL PSYCHIATRY (2003)
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat
RS Martin et al.
PSYCHOPHARMACOLOGY (2003)
Cannabis use and dimensions of psychosis in a nonclinical population of female subjects
H Verdoux et al.
SCHIZOPHRENIA RESEARCH (2003)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology
C Grillon
BIOLOGICAL PSYCHIATRY (2002)
Endocrine effects of marijuana
TT Brown et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
CB1 receptors in the preoptic anterior hypothalamus regulate win 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia
SM Rawls et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2002)
Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat
CC Stanley-Cary et al.
BEHAVIOURAL PHARMACOLOGY (2002)
The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats
M Schneider et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Chronic corticosterone treatment alters sensory gating in C3H mice
KE Stevens et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Are cannabinoid receptor knockout mice animal models for schizophrenia?
M Fritzsche
MEDICAL HYPOTHESES (2001)
Cold-induced increment in rat adrenal gland type II deiodinase is corticosterone dependent
B Anguiano et al.
ENDOCRINE (2001)
Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland
S González et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
